CEO Nikhil Lalwani dismissed the impact of tariffs on the company, stating that over 90% of the total revenues come from finished goods manufactured in the U.S. “While we await the administration's ...

Specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) announced in Q2 CY2025, with sales up 53.1% year on year ...

ANI Pharmaceuticals Inc. (ANIP) on Friday reported second-quarter net income of $8.5 million, after reporting a loss in the same period a ...

Shares of ANI Pharmaceuticals soared after the company raised its full-year guidance on the back of strong sales and profit gains in the second quarter. The stock was up 18.5% at $81.79 in premarket ...

ANI Pharmaceuticals ANIP +0.93% Get Free Report is preparing to release its quarterly earnings on Friday, 2025-08-08. Here's ...

ANIP has shown strong sales growth, especially in generics and rare disease segments, but faces persistent margin compression ...